Microangiopathic hemolytic anemia secondary to cyclosporine therapy in a heart and liver transplant recipient.
Oteo
J F
JF
Alonso-Pulpón
L
L
Diez
J L
JL
Camacho
C
C
Expósito
C
C
González
A
A
Serrano-Fiz
S
S
D000328:Adult; D000744:Anemia, Hemolytic, Autoimmune / Q000139:chemically induced* / Q000473:pathology; D002196:Capillaries / Q000473:pathology; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects*; D016027:Heart Transplantation / Q000473:pathology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D016031:Liver Transplantation / Q000473:pathology*; D008297:Male; D010488:Polyarteritis Nodosa / Q000139:chemically induced* / Q000473:pathology; D011183:Postoperative Complications / Q000139:chemically induced* / Q000473:pathology; D011697:Purpura, Thrombotic Thrombocytopenic / Q000139:chemically induced* / Q000473:pathology; D012867:Skin / Q000098:blood supply
D007166:Immunosuppressive Agents; D016572:Cyclosporine